Regeneron Pharmaceuticals

REGN(Regeneron Pharmaceuticals)

$786.73-1.02%

REGN(Regeneron Pharmaceuticals) Price Prediction Summary

AI-Generated
As of September 26, 2026, REGN is trading above its major moving averages, but momentum is deteriorating. MACD and MA20 both flash sell signals while RSI remains neutral, creating a bearish momentum divergence despite constructive price structure. The key uncertainty: whether price can defend the MA50 support level \(776.79\) or rolls over into the 750–760 zone. Watch the 776–780 support and any break below for confirmation of momentum breakdown.
Technical Indicators
Momentum Divergence, Sell Signals

Price above key moving averages, but momentum indicators flash sell signals with neutral RSI.

Key Trading Levels

How Gate Predicts REGN(Regeneron Pharmaceuticals) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of September 26, 2026, **REGN technical analysis** presents a mixed setup with a bearish momentum edge. The stock is trading above its 20-day, 50-day, and 200-day moving averages—MA20 at 801.89, MA50 at 776.79, and MA200 at 735.69—establishing a bullish price structure. However, MACD at 1.88 has triggered a sell signal, indicating deteriorating momentum and a potential loss of upside steam. The RSI at 48.03 sits neutral, neither overbought nor oversold, suggesting the move lacks conviction in either direction. The divergence is critical: while price levels remain constructive, the momentum indicators are already rolling over, typical of late-stage rallies where structure holds but sellers gain control. The near-term REGN price forecast hinges on whether the stock can hold above MA50 support or if accelerating momentum decay triggers a pullback. Watch for continuation below the 776–780 zone as the key variable for confirming momentum weakness.
IndicatorValueSignal
Exponential Moving Average (10)794.9789
Sell
Exponential Moving Average (100)746.5162
Buy
Exponential Moving Average (20)796.3783
Sell
Exponential Moving Average (200)724.865
Buy
Exponential Moving Average (30)791.0614
Sell
Exponential Moving Average (50)773.9793
Buy
Hull Moving Average (9)800.6956
Sell
Ichimoku Base Line (9, 26, 52, 26)814.4562
neutral
Moving Averages Summary—
neutral
Simple Moving Average (10)790.471
Sell
Simple Moving Average (100)711.5606
Buy
Simple Moving Average (20)801.8865
Sell
Simple Moving Average (200)735.6861
Buy
Simple Moving Average (30)808.1153
Sell
Simple Moving Average (50)776.7858
Buy
Volume Weighted Moving Average (20)800.5755
Sell
Average Directional Index (14)21.9126
neutral
Awesome Oscillator-9.7462
neutral
Bull Bear Power-4.0372
neutral
Commodity Channel Index (20)-43.8117
neutral
MACD Level (12, 26)1.8834
Sell
Momentum (10)6.55
Buy
Oscillators Summary—
neutral
Relative Strength Index (14)48.0279
neutral
Stochastic %K (14, 3, 3)36.1547
neutral
Stochastic RSI Fast (3, 3, 14, 14)39.6991
neutral
Ultimate Oscillator (7, 14, 28)51.2399
neutral
Williams Percent Range (14)-64.2085
neutral
Technical Summary—
neutral

Market Sentiment

AI-GeneratedNo data yet
Analyst Rating
--
Options Put/Call Ratio
86.4900%
Implied Volatility (IV)
2.5686

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

FAQ

What data is used to generate the REGN(Regeneron Pharmaceuticals) price prediction?

x

REGN(Regeneron Pharmaceuticals) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the REGN(Regeneron Pharmaceuticals) price prediction?

x

How are technical indicators used in the REGN(Regeneron Pharmaceuticals) price prediction?

x

What role does market sentiment play in the REGN(Regeneron Pharmaceuticals) price prediction?

x

What common factors can influence the REGN(Regeneron Pharmaceuticals) price prediction?

x

How can price predictions be used to assess the current market state of REGN(Regeneron Pharmaceuticals)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.